tiprankstipranks
Advertisement
Advertisement

NTRA Stock Latest News

Natera resumed with an Outperform at RBC Capital
The FlyNatera resumed with an Outperform at RBC Capital
2d ago
NTRA
Natera Expands Board, Appoints Thomas Lynch as Director
PremiumCompany Announcements
Natera Expands Board, Appoints Thomas Lynch as Director
8d ago
8K
NTRA
Tesla upgraded, Lululemon downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Tesla upgraded, Lululemon downgraded: Wall Street’s top analyst calls
8d ago
BZ
GH
Natera initiated with a Neutral at Goldman Sachs
PremiumThe Fly
Natera initiated with a Neutral at Goldman Sachs
8d ago
NTRA
Natera, CytoDyn collaborate to advance ctDNA-guided development
PremiumThe Fly
Natera, CytoDyn collaborate to advance ctDNA-guided development
9d ago
CYDY
NTRA
Natera appoints Lynch, Rubin to board of directors
PremiumThe FlyNatera appoints Lynch, Rubin to board of directors
10d ago
NTRA
Natera assumed with an Outperform at Wolfe Research
Premium
The Fly
Natera assumed with an Outperform at Wolfe Research
12d ago
NTRA
CareDx denied request to Supreme Court to revive Natera award
Premium
The Fly
CareDx denied request to Supreme Court to revive Natera award
12d ago
CDNA
NTRA
Natera announces collaboration with Diakonos Oncology for Signatera in RM
PremiumThe Fly
Natera announces collaboration with Diakonos Oncology for Signatera in RM
15d ago
NTRA
Natera enrolls first patients in SIGNAL-ER 101 study
PremiumThe Fly
Natera enrolls first patients in SIGNAL-ER 101 study
16d ago
NTRA
Natera announces expansion into Austin, creating largest sequencing factory
PremiumThe Fly
Natera announces expansion into Austin, creating largest sequencing factory
23d ago
NTRA
Natera announces Expand trial enrolled over 2,000 patients
PremiumThe Fly
Natera announces Expand trial enrolled over 2,000 patients
24d ago
NTRA
FDA approves Genentech’s Tecentriq for adjuvant muscle-invasive bladder cancer
PremiumThe FlyFDA approves Genentech’s Tecentriq for adjuvant muscle-invasive bladder cancer
29d ago
CHRO
NTRA
Signatera CDx approved by FDA as companion diagnostic in MIBC
Premium
The Fly
Signatera CDx approved by FDA as companion diagnostic in MIBC
29d ago
CHRO
NTRA
Cathie Wood’s ARK Investment buys 17.3K shares of Natera today
Premium
The Fly
Cathie Wood’s ARK Investment buys 17.3K shares of Natera today
1M ago
NTRA
Natera price target raised to $249 from $240 at Piper Sandler
PremiumThe Fly
Natera price target raised to $249 from $240 at Piper Sandler
1M ago
NTRA
Natera’s Earnings Call Signals Strong Growth Momentum
PremiumCompany Announcements
Natera’s Earnings Call Signals Strong Growth Momentum
1M ago
NTRA
Natera price target raised to $270 from $250 at Evercore ISI
PremiumThe Fly
Natera price target raised to $270 from $250 at Evercore ISI
1M ago
NTRA
Natera price target raised to $265 from $257 at Baird
PremiumThe Fly
Natera price target raised to $265 from $257 at Baird
1M ago
NTRA
Natera price target raised to $265 from $260 at JPMorgan
PremiumThe FlyNatera price target raised to $265 from $260 at JPMorgan
1M ago
NTRA
Natera price target raised to $265 from $260 at JPMorgan
Premium
The Fly
Natera price target raised to $265 from $260 at JPMorgan
1M ago
NTRA
Natera price target raised to $220 from $215 at Wells Fargo
Premium
The Fly
Natera price target raised to $220 from $215 at Wells Fargo
1M ago
NTRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >